# EDGAR Filing Document

**Accession Number:** 0001729678
**File Stem:** 0001635295-23-000015
**Filing Date:** 2023-2
**Character Count:** 7932
**Document Hash:** cd13bd220b292fb97c8fd0c573c96ea1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001635295-23-000015.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001635295-23-000015

**CONFORMED SUBMISSION TYPE**: 40-17F2

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**EFFECTIVENESS DATE**: 20230210

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
- **CENTRAL INDEX KEY:** 0001729678
- **IRS NUMBER:** 831155988
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 40-17F2
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23330
- **FILM NUMBER:** 23612609

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Global Multi-Strategy Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180626

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Multi-Strategy Global Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180130
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.
- **CENTRAL INDEX KEY:** 0001729678
- **IRS NUMBER:** 831155988
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 40-17F2

**BUSINESS ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286
- **BUSINESS PHONE:** 212-922-6400

**MAIL ADDRESS:**
- **STREET 1:** C/O BNY MELLON INVESTMENT ADVISER, INC.
- **STREET 2:** 240 GREENWICH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10286

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Global Multi-Strategy Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180626

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dreyfus Alcentra Multi-Strategy Global Credit Fund, Inc.
- **DATE OF NAME CHANGE:** 20180130

```

Report of Independent Registered Public
Accounting Firm

The Board of Directors of
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.:

We have examined management of BNY Mellon Alcentra Global Multi-
Strategy Credit Fund, Inc.'s assertion, included in the accompanying
Management Statement Regarding Compliance With Certain Provisions
of the Investment Company Act of 1940, that BNY Mellon Alcentra
Global Multi-Strategy Credit Fund, Inc. (the "Fund"), the sole series of
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc., complied
with the requirements of subsections (b) and (c) of Rule 17f-2 under the
Investment Company Act of 1940 (the Act) (the specified requirements)
as of August 31, 2022. BNY Mellon Alcentra Global Multi-Strategy
Credit Fund, Inc. management is responsible for its assertion. Our
responsibility is to express an opinion on management's assertion
about the Fund's compliance with the specified requirements based on
our examination.

Our examination was conducted in accordance with attestation
standards established by the AICPA. Those standards require that we
plan and perform the examination to obtain reasonable assurance about
whether management's assertion about compliance with the specified
requirements is fairly stated, in all material respects. An examination
involves performing procedures to obtain evidence about whether
management's assertion is fairly stated in all material respects. The
nature, timing, and extent of the procedures selected depend on our
judgement, including an assessment of the risks of material
misstatement of management's assertion, whether due to fraud or error.
We believe that the evidence we obtained is sufficient and appropriate
to provide a reasonable basis for our opinion.

We are required to be independent and to meet our other ethical
responsibilities in accordance with relevant ethical requirements relating
to the engagement.

Included among our procedures were the following tests performed as
of August 31, 2022, and with respect to agreement of security
purchases and sales, for the period from May 31, 2022 (the date of the
Fund's last examination), through August 31, 2022:

1.	Confirmation with the Custodian of all securities held, hypothecated,
pledged or placed in escrow or out for transfer with brokers, pledgees,
or transfer agents;

2.	Obtained the Custodian reconciliation of security positions held by
institutions in book entry form (e.g., the Federal Reserve Bank, The
Depository Trust Company and various sub-custodians) to Custodian
records and verified that reconciling items were cleared in a timely
manner;

3.	Reconciliation of the Fund's securities per the books and records of the
Fund to those of the Custodian;

4.	Agreement of pending purchase and sale activity for the
Fund as of August 31, 2022, if any, to documentation of
corresponding subsequent bank statements;

5.	Agreement of five security purchases and five security sales or
maturities, since the date of the last examination, from the
books and records of the Fund to corresponding bank
statements;
6.	Confirmation of all repurchase agreements with broker(s)/bank(s)
and/or agreement of corresponding subsequent cash receipts to
bank statements and agreement of underlying collateral with the
Custodian records, if any;

7.	Review of the BNY Mellon Asset Servicing Custody and Securities
Lending Services Service Organization Control Report ("SOC 1
Report") for the period July 1, 2021 - June 30, 2022 and noted no
relevant findings were reported in the areas of Asset Custody and
Trade Settlement.

Our examination does not provide a legal determination on the Fund's
compliance with specified requirements.

In our opinion, management's assertion that the Fund complied with the
requirements of subsections (b) and (c) of Rule 17f-2 of the Investment
Company Act of 1940 as of August 31, 2022, with respect to securities
reflected in the investment accounts of the Fund is fairly stated, in all
material respects.

This report is intended solely for the information and use of
management and The Board of Directors of BNY Mellon Alcentra
Global Multi-Strategy Credit Fund, Inc. and the Securities and
Exchange Commission and is not intended to be and should not be
used by anyone other than these specified parties.

/s/ KPMG LLP

New York, New York
February 10, 2023

				February 10, 2023
  Management Statement Regarding
Compliance With Certain Provisions of the
Investment Company Act of 1940

We, as members of management of BNY Mellon Alcentra Global Multi-
Strategy Credit Fund, Inc. (the "Fund"), the sole series of BNY Mellon
Alcentra Global Multi-Strategy Credit Fund, Inc. is responsible for
complying with the requirements of subsections (b) and
(c) of Rule 17f-2, "Custody of Investments by Registered Management
Investment Companies" of the Investment Company Act of 1940. We
are also responsible for establishing and maintaining effective internal
controls over compliance with those requirements. We have performed
an evaluation of the Fund's compliance with the requirements of
subsections (b) and (c) of Rule 17f-2 as of August 31, 2022 and for the
period from May 31, 2022 (the date of the Fund's last examination)
through August 31, 2022.

Based on the evaluation, we assert that the Fund was in compliance
with the requirements of subsections (b) and (c) of Rule 17f-2 of the
Investment Company Act of 1940 as of August 31, 2022 and for the
period from May 31, 2022 (the date of  the  Fund's  last  examination)
through August 31, 2022, with respect to securities reflected in the
investment accounts of the Fund.

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc.

Jim Windels
Treasurer

```